Literature DB >> 25954049

High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection.

Daniel C Beachler1, Yingshi Guo2, Wiehong Xiao2, Robert D Burk3, Howard Minkoff4, Howard D Strickler5, Ross D Cranston6, Dorothy J Wiley7, Lisa P Jacobson8, Kathleen M Weber9, Joseph B Margolick2, Elizabeth A Sugar10, Susheel Reddy11, Maura L Gillison2, Gypsyamber D'Souza8.   

Abstract

The association between oral human papillomavirus 16 (HPV16) DNA load and infection clearance was evaluated among 88 individuals with oral HPV16 infection who were identified within a prospective cohort of 1470 HIV-infected and uninfected individuals. Oral rinse specimens were collected semiannually for up to 5 years. The oral HPV16 load at the time of the first positive test result was significantly associated with the time to clearance of infection (continuous P trends <.01). Notably, clearance rates by 24 months were 41% and 94% in the highest and lowest HPV16 load tertiles (P = .03), respectively. High oral HPV16 load warrants consideration as a biomarker for infection persistence, the presumed precursor of HPV16-associated oropharyngeal cancer.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; oral HPV; oropharyngeal cancer; persistence; viral load

Mesh:

Year:  2015        PMID: 25954049      PMCID: PMC4621250          DOI: 10.1093/infdis/jiv273

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  A quantification of human cells using an ERV-3 real time PCR assay.

Authors:  C C Yuan; W Miley; D Waters
Journal:  J Virol Methods       Date:  2001-02       Impact factor: 2.014

2.  Automated high throughput DNA isolation for detection of human papillomavirus in oral rinse samples.

Authors:  Tatevik R Broutian; Xin He; Maura L Gillison
Journal:  J Clin Virol       Date:  2011-01-26       Impact factor: 3.168

3.  Prevalence of oral HPV infection in the United States, 2009-2010.

Authors:  Maura L Gillison; Tatevik Broutian; Robert K L Pickard; Zhen-you Tong; Weihong Xiao; Lisa Kahle; Barry I Graubard; Anil K Chaturvedi
Journal:  JAMA       Date:  2012-01-26       Impact factor: 56.272

4.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

5.  Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study.

Authors:  Long Fu Xi; James P Hughes; Philip E Castle; Zoe R Edelstein; Chunhui Wang; Denise A Galloway; Laura A Koutsky; Nancy B Kiviat; Mark Schiffman
Journal:  J Infect Dis       Date:  2011-03-16       Impact factor: 5.226

Review 6.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

7.  Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study.

Authors:  Christine M Pierce Campbell; Aimée R Kreimer; Hui-Yi Lin; William Fulp; Michael T O'Keefe; Donna J Ingles; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-09

8.  Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.

Authors:  Daniel C Beachler; Elizabeth A Sugar; Joseph B Margolick; Kathleen M Weber; Howard D Strickler; Dorothy J Wiley; Ross D Cranston; Robert D Burk; Howard Minkoff; Susheel Reddy; Weihong Xiao; Yingshi Guo; Maura L Gillison; Gypsyamber D'Souza
Journal:  Am J Epidemiol       Date:  2014-12-04       Impact factor: 4.897

9.  A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation.

Authors:  Patti E Gravitt; Robert D Burk; Attila Lorincz; Rolando Herrero; Allan Hildesheim; Mark E Sherman; Maria Concepcion Bratti; Ana Cecilia Rodriguez; Kathy J Helzlsouer; Mark Schiffman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-06       Impact factor: 4.254

10.  High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010.

Authors:  Anil K Chaturvedi; Barry I Graubard; Robert K L Pickard; Weihong Xiao; Maura L Gillison
Journal:  J Infect Dis       Date:  2014-03-12       Impact factor: 5.226

View more
  8 in total

1.  Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.

Authors:  Gypsyamber D'Souza; Gwendolyn Clemens; Tanya Troy; Rachel G Castillo; Linda Struijk; Tim Waterboer; Noemi Bender; Phillip M Pierorazio; Simon R Best; Howard Strickler; Dorothy J Wiley; Robert I Haddad; Marshall Posner; Carole Fakhry
Journal:  Cancer Prev Res (Phila)       Date:  2019-08-16

Review 2.  The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.

Authors:  Theresa Guo; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2016-05-06       Impact factor: 6.860

3.  Quantitative Oral HPV16 and HPV18 Detection in Persons Attending Dental Clinics.

Authors:  Helen C Stankiewicz Karita; Amalia Magaret; Meei-Li Huang; Keith R Jerome; Quinne Feng; Anna Wald
Journal:  Sex Transm Dis       Date:  2020-02       Impact factor: 2.830

Review 4.  Current and Emerging Molecular Tests for Human Papillomavirus-Related Neoplasia in the Genomic Era.

Authors:  Sixto M Leal; Margaret L Gulley
Journal:  J Mol Diagn       Date:  2017-03-18       Impact factor: 5.568

5.  HPV-16 in a distinct subset of oral epithelial dysplasia.

Authors:  Mark A Lerman; Soulafa Almazrooa; Neal Lindeman; Dimity Hall; Alessandro Villa; Sook-Bin Woo
Journal:  Mod Pathol       Date:  2017-08-11       Impact factor: 7.842

6.  Partner Human Papillomavirus Viral Load and Incident Human Papillomavirus Detection in Heterosexual Couples.

Authors:  Mary K Grabowski; Xiangrong Kong; Ronald H Gray; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Steven J Reynolds; Maria J Wawer; Andrew D Redd; Stephen Watya; Thomas C Quinn; Aaron A R Tobian
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

7.  Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners.

Authors:  Anne S Tsao; Vassiliki Papadimitrakopoulou; Heather Lin; Ming Guo; J Jack Lee; F Christopher Holsinger; Waun Ki Hong; Erich M Sturgis
Journal:  Infect Agent Cancer       Date:  2016-04-27       Impact factor: 2.965

8.  Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples.

Authors:  David Guenat; Véronique Dalstein; Frédéric Mauny; Maëlle Saunier; Jenny Briolat; Christine Clavel; Didier Riethmuller; Christiane Mougin; Jean-Luc Prétet
Journal:  Papillomavirus Res       Date:  2018-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.